← Back
$VRTX All transactions

VERTEX PHARMACEUTICALS INC / MA

▼ SELL 10b5-1 Plan

$ Value

$2.0M

Shares

4,500

Price

$450

Filed

Dec 5

Insider

Name

Tatsis Ourania

Title

EVP, Chief Reg. & Quality Off.

CIK

0001789815

Roles

Officer

Transaction Details

Transaction Date

2025-12-03

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

46,793

Footnotes

Transaction made pursuant to Dr. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 08/21/2025. | Open market sales reported on this line occurred at a weighted average price of $449.99 (range $449.99 to $450.00). | Dr. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Filing Info

Accession No.

0000875320-25-000244

Form Type

4

Issuer CIK

0000875320

Tatsis Ourania's History

Date Ticker Type Value
2026-01-22 VRTX A $0
2026-01-22 VRTX A $0
2026-01-07 VRTX $2.1M
2025-12-03 VRTX $2.0M
2025-07-25 VERV D
2025-07-25 VERV D
2025-06-05 VERV A $0

Other Insiders at VRTX (90d)

Insider Bought Sold Last
SACHS BRUCE I 2026-04-15
WAGNER CHARLES F JR
EVP, CO & FO
2026-01-22
LEIDEN JEFFREY M
Executive Chairman
2026-01-22
Garber Alan M 2026-04-15
Sachdev Amit
EVP Chief Patient & Ext Af Off
2026-01-22
Upadhyay Suketu 2026-04-15
ALTSHULER DAVID
EVP, Chief Scientific Officer
2026-01-22
Kewalramani Reshma
CEO & President
2026-01-22
Biller Jonathan
EVP and Chief Legal Officer
2026-01-22
Tatsis Ourania
EVP, Chief Reg. & Quality Off.
2026-01-22
Bozic Carmen
EVP and CMO
$1.1M 2026-03-27
Liu Joy
EVP and Chief Legal Officer
$439K 2026-04-01
Ambrose Kristen
SVP & Chief Accounting Officer
2026-01-22
Atkinson Edward Morrow III
EVP, Chief Technical Ops. Off.
2026-01-22
McKechnie Duncan
EVP, Chief Commercial Officer
2026-01-22